GHRP-6 (5mg) About This Product
GHRP-6 (5mg) is a synthetic growth hormone–releasing hexapeptide used in endocrine, neuroendocrine, and metabolic research. The GHRP-6 peptide has a molecular weight of ~840 Da and incorporates L- and D-amino acid residues, which can affect proteolytic susceptibility and receptor-interaction profiles in experimental settings.
GHRP-6 has been examined as a synthetic agonist of the growth hormone secretagogue receptor-1a (GHS-R1a), also called the ghrelin receptor. Receptor activation initiates Gq/phospholipase C (PLC) signaling and calcium-dependent intracellular cascades relevant to growth hormone release and related neuroendocrine signaling under controlled research conditions.
This product is supplied as a sterile, lyophilized powder with ≥98% purity in a sealed research vial. Laboratories that buy GHRP-6 peptide commonly use the 5 mg format for non-clinical study designs.
GHRP-6 (5mg) Key Features and Benefits
- GHS-R1a (Ghrelin Receptor) Agonist: Supports receptor pharmacology and signaling assays
- D-Amino Acid Composition: Associated with improved experimental stability
- Low Molecular Weight (~840 Da): Practical for controlled handling
- Lyophilized Powder: Supports stability and flexible preparation
- Purity ≥98%: Suitable for research and analytical workflows
- Sealed, Labeled Vial: Supports traceability and documentation
GHRP-6 (5mg) Mechanism & Research Applications
GHRP-6 acts at GHS-R1a, a GPCR expressed in the pituitary, hypothalamus, central nervous system, and select peripheral tissues. Activation triggers Gq/PLC-dependent signaling, leading to inositol triphosphate (IP₃) generation, intracellular calcium mobilization, and kinase activation. These cascades are used to study growth hormone secretion dynamics, metabolic sensing, and gene-expression programs linked to cellular stress, inflammatory signaling, and apoptosis-associated pathways.
In research contexts, GHRP-6 is used to probe GHS-R1a activation kinetics, tissue-specific receptor expression, and downstream signal-transduction networks.
Primary Research Domains
- Receptor Pharmacology: Ligand-response profiling, second-messenger readouts, structure–activity work
- Neuroscience: Learning/memory endpoints, synaptic plasticity, dopaminergic involvement
- Ischemia & Cellular Stress: Apoptosis markers and neuroinflammatory signaling
- Extracellular Matrix & Tissue Remodeling: Matrix signatures, migration, wound-model profiling
- Cardiac Stress Models: Oxidative injury and necrosis-related endpoints
- Motivation & Reward Circuitry: Region-specific behavioral outputs
Preclinical Research Summary
- Neural Plasticity & Memory: Extinction learning, amygdala-associated LTD, memory encoding
- Ischemic Brain Injury: Apoptosis-associated markers and neuroinflammation readouts
- Dopaminergic Mapping: GHS-R expression in substantia nigra linked to motor phenotypes
- ECM Remodeling: Collagen deposition and proteome-level repair signatures
- Myocardial Injury/Oxidative Stress: Oxidative injury indices and necrosis markers
- Motivation & Reward-Seeking: CNS region–dependent effects on motivated behavior
GHRP-6 (5mg) Dosing & Observed Effects in Research
Published studies report microgram-to-milligram use depending on model and design, including cell-based assays, tissue explants, rodent studies, and large-animal preclinical models.
Observed endpoints reported in research settings include:
- Growth hormone elevation
- Learning/memory-related behavioral changes
- Apoptosis and necrosis signaling markers
- Inflammatory cytokine pathway modulation
- Oxidative-stress and antioxidant-response markers
- Extracellular-matrix expression and collagen deposition
- Reward-seeking and motivated-behavior outputs
- Dopaminergic neuron response modulation
All findings remain preclinical and model-specific.
GHRP-6 (5mg) Storage, Safety & References
Store lyophilized material protected from light and moisture:
- Short-term: 2–8°C (days to weeks)
- Long-term: −20°C or lower (−80°C preferred). Avoid repeated freeze–thaw cycles.
Reconstitute using sterile laboratory-grade diluent under aseptic technique. Handle with standard PPE and dispose of per institutional requirements. Laboratories that order GHRP-6 peptide are responsible for compliance.
References
https://pubmed.ncbi.nlm.nih.gov/8903947
https://pmc.ncbi.nlm.nih.gov/articles/PMC40592
https://pubmed.ncbi.nlm.nih.gov/9543138
https://www.pnas.org/doi/10.1073/pnas.1313798111
https://pubmed.ncbi.nlm.nih.gov/16989643
https://onlinelibrary.wiley.com/doi/10.1155/2016/4361702
Compliance Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use.
